The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final analysis of relapse-free survival in a multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine after resection of high-risk melanoma.
 
Craig L. Slingluff
Research Funding - Celldex (Inst); GlaxoSmithKline (Inst); Immatics (Inst); Merck (Inst); Polynoma (Inst); Theraclion (Inst)
Patents, Royalties, Other Intellectual Property - University of Virginia Licensing and Ventures Group
(OPTIONAL) Uncompensated Relationships - CureVac (Inst)
 
Brent A. Blumenstein
Employment - Trial Architecture Consulting
 
Karl D. Lewis
Honoraria - Array BioPharma
Consulting or Advisory Role - Array BioPharma; Merck; Regeneron; Roche
Research Funding - alkermes (Inst); Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Iovance Biotherapeutics (Inst); Kartos Therapeutics (Inst); Merck (Inst); Nektar (Inst); Neon Therapeutics (Inst); OncoSec (Inst); Regeneron (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - alkermes; Merck; Neon Therapeutics; Regeneron; Roche/Genentech
(OPTIONAL) Uncompensated Relationships - Regeneron; Roche/Genentech
 
Robert Hans Ingemar Andtbacka
Employment - Merck Sharp & Dohme (I); Novartis (I); Seven and Eight Biopharmaceuticals
Stock and Other Ownership Interests - Merck Sharp & Dohme (I); Novartis (I)
Honoraria - Novartis
Consulting or Advisory Role - Merck/Schering Plough; Novartis; Pfizer
Research Funding - Amgen (Inst); Idera (Inst); Oncolys BioPharma (Inst); OncoSec (Inst); Provectus (Inst); Takara Bio (Inst); Viralytics (Inst); X4 Pharma (Inst)
 
John Robert Hyngstrom
Honoraria - Castle Biosciences
Research Funding - Amgen (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Castle Biosciences
 
Mohammed M. Milhem
Honoraria - Amgen; Array BioPharma; Blueprint Medicines; Immunocore; Novartis; Trieza Therapeutics
Consulting or Advisory Role - Amgen; Array BioPharma; Blueprint Medicines; Immunocore; Novartis; Trieza Therapeutics
Research Funding - Amgen (Inst); E.R. Squibb Sons, LLC (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Prometheus (Inst)
 
Svetomir Markovic
Research Funding - Bristol-Myers Squibb; Seagen; Vavotar Life Sciences
 
Omid Hamid
Honoraria - Array BioPharma; Bristol-Myers Squibb; Novartis; Sanofi/Regeneron
Consulting or Advisory Role - Aduro Biotech; Akeso Biopharma; Amgen; Array BioPharma; BeiGene; Bristol-Myers Squibb; Genentech; GlaxoSmithKline; Immunocore; Incyte; Janssen; Merck; NextCure; Novartis; Regeneron; Roche; Sanofi; Seagen; Tempus; Zelluna
Speakers' Bureau - Array BioPharma; Bristol-Myers Squibb; Novartis; Sanofi/Regeneron
Research Funding - Aduro Biotech (Inst); Akeso Biopharma (Inst); Amgen (Inst); Arcus Biosciences (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); CytomX Therapeutics (Inst); Exelixis (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Immunocore (Inst); Incyte (Inst); Iovance Biotherapeutics (Inst); MedImmune (Inst); Merck (Inst); Merck Serono (Inst); Moderna Therapeutics (Inst); NextCure (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Roche (Inst); Sanofi (Inst); Seagen (Inst); Torque (Inst); Zelluna (Inst)
 
Leonel Fernando Hernandez-Aya
Consulting or Advisory Role - Massive Bio
Speakers' Bureau - Sanofi/Regeneron
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Immunocore (Inst); MedImmune (Inst); Merck (Inst); Merck Serono (Inst); Polynoma (Inst); Regeneron (Inst); Roche/Genentech (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Sanofi/Regeneron
 
Tawnya Lynn Bowles
Research Funding - Amgen (Inst); Genentech (Inst); Idera (Inst); MAVIS (Inst); Replimune (Inst)
 
Prejesh Philips
Research Funding - Polynoma (Inst)
Travel, Accommodations, Expenses - Boston Scientific; Transenterix
 
Sekwon Jang
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; EMD Serono; Novartis; Sanofi; Sun Biopharma
 
Jose Lutzky
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Novartis
Speakers' Bureau - Array BioPharma; Novartis; Regeneron
Research Funding - Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Elios Pharmaceutical (Inst); Genentech/Roche (Inst); Immunocore (Inst); Incyte (Inst); Iovance Biotherapeutics (Inst); Merck (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Viralytics (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pfizer
 
Anna Bar
Consulting or Advisory Role - Castle Biosciences (Inst)
Research Funding - Castle Biosciences (Inst); PellePharm (Inst)
 
Peter D. Beitsch
Stock and Other Ownership Interests - Targeted Medical Education, Inc.
Research Funding - InVitae
Expert Testimony - Dune Medical Devices; ImpediMed
(OPTIONAL) Uncompensated Relationships - MedNeon